SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003351
Filing Date
2018-04-30
Accepted
2018-04-30 16:19:04
Documents
7
Period of Report
2018-06-19
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235484zdef14a.htm DEF 14A 854638
2 G348071.JPG g348071.jpg GRAPHIC 16120
3 G181137.JPG g181137.jpg GRAPHIC 5277
4 G634942.JPG g634942.jpg GRAPHIC 108183
5 G1034437.JPG g1034437.jpg GRAPHIC 90634
6 G30962BGI001.GIF g30962bgi001.gif GRAPHIC 115720
7 G30962BGI002.GIF g30962bgi002.gif GRAPHIC 61845
  Complete submission text file 0001047469-18-003351.txt   1404354
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36306 | Film No.: 18790037
SIC: 2834 Pharmaceutical Preparations